You searched for "sinus"
BCLA Presidential Address highlights the opportunities for growth in contact lens sector
The new President of the BCLA has used his inaugural address to urge the sector to have “meaningful” conversations after eye exams and deliver “better vision outcomes” for patients.‘At risk’ corneas are more easily identified with SCORE
Risk assessment of post-LASIK corneal ectasia in refractive surgery patients is now a more exact, objective, evaluation thanks to the work of Heidelberg Engineering and a leading research partner in Paris.Leah takes a big jump to a better life with Sight Scotland
Leah Cameron, 22, who suffered vision impairment through an acquired brain injury, is getting ready to take a big jump forward to say thank you to the charity which has transformed her life.Shetland actress stars in RNIB’s general election film
4 July 2024
|
politics, RNIB, charity, blind, partially sighted, patient experience, 2024, scotland, election
Sandra Voe (87) from Shetland, has stared in a film which highlights the need for accessible voting for blind and partially sighted people.
AI-enabled smart cane scoops award for transforming lives of people with sight loss
31 March 2025
|
sight loss, RNIB, Award Winning, Product Design, WeWALK Smart Cane, artificial intelligence, technology
An AI-enabled smart cane designed to transform the lives of people with sight loss has won a prestigious international design award. The WeWALK Smart Cane was recognised by the iF International Forum Design at this year’s product design awards. The...
FMLM Conference 2024
26 March 2024
by Somain Verma, Ophthalmology Registrar (ST2), Northampton General Hospital. Clinical leadership is more important than ever. With an ever-increasingly burdened health system, we must assure that appropriate resources and systems are in place to maintain an effective and efficient health...
Licence to save: a UK survey of anti-VEGF use for the eye
1 February 2017
| Sofia Rokerya
|
EYE - Vitreo-Retinal
This comment article highlights the controversy that exists in the choice for anti-VEGF drugs used for treatment of macular oedema and wet age-related macular degeneration (AMD). Two existing licensed drugs for macular oedema are ranibizumab (Lucentis) and aflibercept (Eylea). A...
Blind Edinburgh man named Young Volunteer of the Year
Daryl Stewart (23), a long-standing volunteer with sight loss charity RNIB Scotland, has been awarded the Special Recognition Award for Young Volunteer of the Year at the 2025 Inspiring Volunteer Awards, run by Volunteer Edinburgh. The award ceremony, which took...The happiness coefficient: Pete’s hidden curriculum Part 5
4 December 2023
| Peter Cackett
|
EYE - General
Jeremy: Come on, man, shake your booty! Tonight even Paxman’s out, hoovering up lines of crank off Krishnan Guru-Murthy. Tonight’s the big one.Mark: Jeremy, all rational people agree it’s a truth self-evident that it’s impossible to have a good time...
Quality matters in the management of serious eye disorders
1 June 2019
| Rod McNeil
|
EYE - Cataract, EYE - Glaucoma, EYE - Neuro-ophthalmology, EYE - Vitreo-Retinal
The author discusses the first quality standard for serious eye disorders from NICE and takes a look at new care models for enhanced service delivery. Patient backlogs pose risks to patient safety, with research showing that people are losing sight...
Redefining healthcare through the eyes
4 February 2025
| Ashkan Eliasy
|
EYE - Cornea, EYE - Imaging, EYE - Neuro-ophthalmology, EYE - General
The future of healthcare is being shaped by innovation in eyecare and in particular a field known as oculomics. This discipline leverages ocular biomarkers to provide insights into various health conditions, including cardiovascular diseases and psychological or neurological disorders [1]....
COVID-19 elective oculoplastic consent proforma
1 July 2020
The advent of COVID-19 will continue to impose major adaptations in how we as surgeons practise and offer elective surgery going forward. In addition to how we try to adapt to make our practice as safe for the patient and our teams as...